Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
THE OPPORTUNITY
Vir Biotechnology seeks a Vice President, Strategy & Portfolio Planning, reporting to the Chief Business Officer, who will be responsible for guiding the company's strategy and optimizing its portfolio of programs products, and partnerships. This visible leadership position works across all business units.
You will serve as a thoughtful strategic partner to the CBO and executive leadership team, driving corporate strategy and portfolio prioritization. You will optimize Vir Bio's business, translate enterprise-level strategies into actions, and align the organization to the strategy. Working closely with competitive intelligence, business development, and alliance management CBO sub-teams, you will develop Vir Bio's long-term strategic plan and lead integrated asset-level strategies across clinical and preclinical-stage programs. An enterprise leader, you will apply analytical rigor, translate complex clinical, scientific, and financial data into clear recommendations, articulate strategy, and work collaboratively across the company.
You’ll thrive in this role if you love shaping big-picture strategy in fast-moving biotech environments, get energized by steering clinical-stage portfolios to provide the greatest patient benefit, and leveraging your experience across organizations both large and small.
This role is in our San Francisco headquarters with at least 3 days per week in the office.
WHAT YOU'LL DO
Corporate Strategy
- Lead the development and evolution of Vir Bio's long-term strategic plan in partnership with the CBO, executive leadership, and Board of Directors
- Adapt corporate strategy in response to emerging clinical data, evolving market dynamics, and competitive landscape shifts
- Working closely with the CEO, CBO, and CEO Chief of Staff, conceptualize and create board materials for quarterly board meetings and strategic offsites
- Drive scenario planning and options analysis to inform critical business decisions and enable agile executive team decision-making
- Contribute to investor communications and narratives supporting company growth
- Design and manage strategic planning cycles, leadership meetings, and governance forums to enable clear priorities, decision-making, and execution tracking
Portfolio Planning
- Partner with the CBO and executive leadership to shape Vir Bio's long-term portfolio strategy, evaluating diversification pathways and strategic options under different capital, partnership, and market scenarios
- Define portfolio strategy frameworks and valuation methodologies (NPV analysis, risk-adjusted valuations, scenario modeling) that inform corporate development priorities, investment decisions, and strategic prioritization
- Develop and implement analytical frameworks and decision-making tools (including those leveraging AI/ML) that enhance organizational capabilities, driving data-driven strategic maturity and alignment across the organization
- Conduct portfolio-level strategic analysis to identify gaps, optimize risk profile, and maximize financial returns, influencing business development target identification and deal thesis development in close partnership with senior leadership
- Establish portfolio metrics, KPIs, and measurement frameworks to evaluate performance against strategic objectives, integrating competitive intelligence, emerging clinical data, and market insights into decision-making
- Engage external advisors, consultants, and KOLs to inform portfolio strategy and validate strategic assumptions
#LI-AS1
#LI-Onsite
WHO WE ARE AND WHAT WE OFFER
The expected salary range for this position is $300,000 to $350,000 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.